Immunotherapies will never be the same.
The Premise Behind SAb
Ready for rapid response. Because we can.
The speed and sophistication of our platform means we can address global health threats in ways only we can. We’re ready to respond quickly to epidemic-level pathogens, and we’re already developing treatments for some of the world’s most imminent health threats.
-
Awarded multimillion-dollar contract from the U.S. Department of Defense to develop and test an accelerated and effective rapid response capability, at scale
-
Recognized as the only therapeutic platform to address priority pathogens by the World Health Organization
Advanced engineering and a refined suite of technologies optimized over nearly two decades
